Blue Charm blog

Chronicle Companies and Blue Charm Adherence have announced a strategic partnership to enhance the use of Real-World Data (RWD) in healthcare applications. By combining Chronicle's expertise in medical publishing with Blue Charm's Patient Insights platform, the collaboration aims to improve patient outcomes and empower healthcare professionals with actionable data. This initiative marks a significant step in advancing patient-centered care using RWD.

A groundbreaking partnership between Obesity Matters and Blue Charm Adherence aimed at increasing education and awareness about obesity and its management options.

The following article discusses the significant role genetics play in obesity, alongside lifestyle factors like diet and exercise. It highlights specific genetic variants, such as those in the FTO and MC4R genes, that increase susceptibility to obesity by affecting appetite, metabolism, and energy storage. This emphasizes the need to understand obesity's multifactorial nature to avoid stigma and promote comprehensive health strategies that include genetic insights for personalized interventions.

The following article discusses how IBD affects daily life with unpredictable flare-ups causing severe symptoms like pain and fatigue, significantly impacting physical and mental well-being. A survey found that 94% of people with IBD experience regular disruptions to their quality of life. Despite these challenges, coping strategies such as building a support network and seeking medical advice can help manage the condition.

The article highlights the critical importance of timely access to healthcare in Canada, underscoring it as a cornerstone of societal function. Despite the country's celebrated universal healthcare system, challenges such as varying wait times for specialists and diagnostic tests persist across provinces and territories. Access to healthcare professionals is crucial not only for managing chronic conditions effectively but also for early detection and treatment, thus directly influencing health outcomes and overall quality of life for Canadians.

In this insightful interview, Nadia shares her journey with Inflammatory Bowel Disease (IBD), from the challenges of diagnosis to advocating for herself and others through her platform, Gutsy Girl Diaries. She emphasizes the importance of exploring all treatment options, the rollercoaster nature of IBD, and finding support in a community. Nadia's story highlights resilience, empowerment, and the transformative power of sharing one's journey.

Emphasizing the necessity for healthcare providers to prioritize patient education. This will not only enhance patient confidence but will also contribute to better disease management, alleviating strain on the healthcare system.

In an interview with Blue Charm, Josh Rheaume, known as "The Asthma Runner," shares his lifelong battle with severe asthma, highlighting the lack of support and education he faced growing up. Despite financial and health challenges, he found solace in running, using his Instagram platform to inspire others facing similar struggles. With aspirations to qualify for the Boston Marathon, Josh aims to redefine the limits imposed by his condition and empower fellow asthma sufferers.

Highlighting a significant gap between patient perception and reality, this article reveals the importance of patient education and access to resources for proper disease management, including medication, symptom awareness, and trigger avoidance.

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients. 

The promise of Real-World Evidence/Data has always been to support clinical decision making with the highest possible quality of evidence. In practice, what does this actually mean and how does it enable us to provide better care for patients? 

Blue Charm Adherence Inc., a leading digital health technology company with a focus on creating a new standard for patient insights, engagement, and real-world evidence generation, is pleased to announce that Dean Michelin will be joining the company as an Account Director effective September 1st, 2023. Dean will play a key role within Blue Charm’s intent to accelerate its position within sample and copayment financial assistance under the brand ONE by Blue Charm™.

Introducing Blue Charm for COPD, a country-wide initiative supporting Canadians living with COPD.

Blue Charm is pleased to share the launch of our latest offering in support of people living with multiple sclerosis.

Blue Charm Adherence, a healthcare technology company, today announced that it has launched its next product offering, Blue Charm Assist.

NKS Health & Blue Charm Adherence Announce Strategic Collaboration on Digital Health Program for People Living With MS.

Blue Charm Adherence partners with the Canadian Pharmacists Association (CPhA) to help provide innovative solutions to enhance Medication Adherence for Patients with Chronic Disease.

The organization is pleased to launch its medication adherence platform within Canada in partnership with the MS Society of Canada.

Acquisition of Symbi Medical, a digital health company that provides patient engagement solutions across multiple medical specialties.

Blue Charm Adherence is pleased to announce that it has formally closed its investment offering utilizing the Nova Scotia Innovation Equity Tax Credit.

We are pleased to announce that in early March, Blue Charm Adherence became a part of the Volta incubation hub in Halifax, joining approximately another 49 technology companies.

The team at Blue Charm Adherence is very happy to report that we have closed the private offering under the Nova Scotia Innovation Equity Tax Credit program.